These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9745236

  • 1. When does Huntington's disease begin?
    Campodonico JR, Aylward E, Codori AM, Young C, Krafft L, Magdalinski M, Ranen N, Slavney PR, Brandt J.
    J Int Neuropsychol Soc; 1998 Sep; 4(5):467-73. PubMed ID: 9745236
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
    Misiura MB, Lourens S, Calhoun VD, Long J, Bockholt J, Johnson H, Zhang Y, Paulsen JS, Turner JA, Liu J, Kara B, Fall E, PREDICT-HD Investigators & Working Group.
    J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
    [Abstract] [Full Text] [Related]

  • 6. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease.
    Harris GJ, Codori AM, Lewis RF, Schmidt E, Bedi A, Brandt J.
    Brain; 1999 Sep; 122 ( Pt 9)():1667-78. PubMed ID: 10468506
    [Abstract] [Full Text] [Related]

  • 7. Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease.
    Jurgens CK, van de Wiel L, van Es AC, Grimbergen YM, Witjes-Ané MN, van der Grond J, Middelkoop HA, Roos RA.
    J Neurol; 2008 Nov; 255(11):1785-91. PubMed ID: 19156490
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease.
    Lawrence AD, Weeks RA, Brooks DJ, Andrews TC, Watkins LH, Harding AE, Robbins TW, Sahakian BJ.
    Brain; 1998 Jul; 121 ( Pt 7)():1343-55. PubMed ID: 9679785
    [Abstract] [Full Text] [Related]

  • 13. Dual tasking impairments are associated with striatal pathology in Huntington's disease.
    Lo J, Reyes A, Pulverenti TS, Rankin TJ, Bartlett DM, Zaenker P, Rowe G, Feindel K, Poudel G, Georgiou-Karistianis N, Ziman MR, Cruickshank TM.
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1608-1619. PubMed ID: 32794343
    [Abstract] [Full Text] [Related]

  • 14. An overview of psychiatric symptoms in Huntington's disease.
    Anderson KE, Marder KS.
    Curr Psychiatry Rep; 2001 Oct; 3(5):379-88. PubMed ID: 11559474
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation.
    Majid DS, Aron AR, Thompson W, Sheldon S, Hamza S, Stoffers D, Holland D, Goldstein J, Corey-Bloom J, Dale AM.
    Mov Disord; 2011 Dec; 26(14):2544-51. PubMed ID: 21932302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.